143 related articles for article (PubMed ID: 22147080)
1. Evaluating breast cancer risk projections for Hispanic women.
Banegas MP; Gail MH; LaCroix A; Thompson B; Martinez ME; Wactawski-Wende J; John EM; Hubbell FA; Yasmeen S; Katki HA
Breast Cancer Res Treat; 2012 Feb; 132(1):347-53. PubMed ID: 22147080
[TBL] [Abstract][Full Text] [Related]
2. Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.
Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Rohan TE; Hankinson SE; Marcantonio ER; Ngo LH
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26625899
[TBL] [Abstract][Full Text] [Related]
3. Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
Banegas MP; John EM; Slattery ML; Gomez SL; Yu M; LaCroix AZ; Pee D; Chlebowski RT; Hines LM; Thompson CA; Gail MH
J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 28003316
[TBL] [Abstract][Full Text] [Related]
4. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women.
Matsuno RK; Costantino JP; Ziegler RG; Anderson GL; Li H; Pee D; Gail MH
J Natl Cancer Inst; 2011 Jun; 103(12):951-61. PubMed ID: 21562243
[TBL] [Abstract][Full Text] [Related]
5. The risk of developing invasive breast cancer in Hispanic women : a look across Hispanic subgroups.
Banegas MP; Leng M; Graubard BI; Morales LS
Cancer; 2013 Apr; 119(7):1373-80. PubMed ID: 23224859
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
[TBL] [Abstract][Full Text] [Related]
7. Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort.
Jantzen R; Payette Y; de Malliard T; Labbé C; Noisel N; Broët P
BMJ Open; 2021 Apr; 11(4):e045078. PubMed ID: 33846154
[TBL] [Abstract][Full Text] [Related]
8. Effect of changing breast cancer incidence rates on the calibration of the Gail model.
Schonfeld SJ; Pee D; Greenlee RT; Hartge P; Lacey JV; Park Y; Schatzkin A; Visvanathan K; Pfeiffer RM
J Clin Oncol; 2010 May; 28(14):2411-7. PubMed ID: 20368565
[TBL] [Abstract][Full Text] [Related]
9. 10-year performance of four models of breast cancer risk: a validation study.
Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
[TBL] [Abstract][Full Text] [Related]
10. Validation of two US breast cancer risk prediction models in German women.
Hüsing A; Quante AS; Chang-Claude J; Aleksandrova K; Kaaks R; Pfeiffer RM
Cancer Causes Control; 2020 Jun; 31(6):525-536. PubMed ID: 32253639
[TBL] [Abstract][Full Text] [Related]
11. Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.
Powell M; Jamshidian F; Cheyne K; Nititham J; Prebil LA; Ereman R
Clin Breast Cancer; 2014 Jun; 14(3):212-220.e1. PubMed ID: 24461459
[TBL] [Abstract][Full Text] [Related]
12. Projecting individualized absolute invasive breast cancer risk in African American women.
Gail MH; Costantino JP; Pee D; Bondy M; Newman L; Selvan M; Anderson GL; Malone KE; Marchbanks PA; McCaskill-Stevens W; Norman SA; Simon MS; Spirtas R; Ursin G; Bernstein L
J Natl Cancer Inst; 2007 Dec; 99(23):1782-92. PubMed ID: 18042936
[TBL] [Abstract][Full Text] [Related]
13. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
14. SNPs and breast cancer risk prediction for African American and Hispanic women.
Allman R; Dite GS; Hopper JL; Gordon O; Starlard-Davenport A; Chlebowski R; Kooperberg C
Breast Cancer Res Treat; 2015 Dec; 154(3):583-9. PubMed ID: 26589314
[TBL] [Abstract][Full Text] [Related]
15. Prospective approach to breast cancer risk prediction in African American women: the black women's health study model.
Boggs DA; Rosenberg L; Adams-Campbell LL; Palmer JR
J Clin Oncol; 2015 Mar; 33(9):1038-44. PubMed ID: 25624428
[TBL] [Abstract][Full Text] [Related]
16. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
Gail MH
J Natl Cancer Inst; 2008 Jul; 100(14):1037-41. PubMed ID: 18612136
[TBL] [Abstract][Full Text] [Related]
17. Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk.
Schonberg MA; Li VW; Eliassen AH; Davis RB; LaCroix AZ; McCarthy EP; Rosner BA; Chlebowski RT; Hankinson SE; Marcantonio ER; Ngo LH
Breast Cancer Res Treat; 2016 Dec; 160(3):547-562. PubMed ID: 27770283
[TBL] [Abstract][Full Text] [Related]
18. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
Kurian AW; Hughes E; Simmons T; Bernhisel R; Probst B; Meek S; Caswell-Jin JL; John EM; Lanchbury JS; Slavin TP; Wagner S; Gutin A; Rohan TE; Shadyab AH; Manson JE; Lane D; Chlebowski RT; Stefanick ML
Cancer; 2021 Oct; 127(20):3742-3750. PubMed ID: 34228814
[TBL] [Abstract][Full Text] [Related]
19. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model.
Gail MH
J Natl Cancer Inst; 2009 Jul; 101(13):959-63. PubMed ID: 19535781
[TBL] [Abstract][Full Text] [Related]
20. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]